Daniel R Chard bought $179k of MED
Chairman & CEO at MEDIFAST INC. 17,678 shares at an average of $10.11, traded Mar 20, 2026, filed Mar 27, 2026.
Score components
- +25RoleCEO
- +12Trade size$179k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +18Price context5% above the 52-week low; 34% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +14.4%, 3m +7.8%, 6m +24.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-021795, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | FTax withholding Common Stock | -7,075 | $9.62 | $68k | 169,171 | Mar 27, 2026 |
| Mar 17, 2026 | FTax withholding Common Stock | -2,638 | $10.05 | $27k | 166,533 | Mar 27, 2026 |
| Mar 20, 2026 | POpen-market purchase Common Stockindirect: Dan and Allyson as Joint Tenants | +17,678 | $10.11 | $179k | 17,678 | Mar 27, 2026 |
| Mar 25, 2026 | FTax withholding Common Stock | -20,095 | $9.59 | $193k | 146,438 | Mar 27, 2026 |
| Mar 25, 2026 | AGrant or award Common Stock | +36,968 | $0.00 | $0 | 183,406 | Mar 27, 2026 |
| Mar 25, 2026 | AGrant or award Common Stock | +4,827 | $0.00 | $0 | 188,233 | Mar 27, 2026 |
Related signals
Other insiders at MEDIFAST INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | MEDIFAST INC | Daniel R Chard Chairman & CEO | $226k 19,089 shares | -13% | |
| 45Moderate | MEDbuy MEDIFAST INC | Parsa Kiai director | $529k 43,150 shares | +6% | |
| 26Weak | MEDbuy MEDIFAST INC | Parsa Kiai director | $52k 4,329 shares | +1% | |
| 45Moderate | MEDbuy MEDIFAST INC | Parsa Kiai director | $843k 72,487 shares | +12% | |
| 30Weak | MEDbuy MEDIFAST INC | Scott Schlackman director | $63k 5,000 shares | +20% | |
| 38Weak | MEDbuy MEDIFAST INC | Daniel R Chard Chairman & CEO | $5,003 381 shares | +0% | |
| 43Moderate | MEDIFAST INC | Jeffrey J Brown director | $11k 155 shares | +4% | |
| 43Moderate | MEDIFAST INC | Michael A. Hoer director | $3,428 50 shares | +1% | |
| 43Moderate | MEDIFAST INC | Scott Schlackman director | $3,627 53 shares | +1% | |
| 43Moderate | MEDIFAST INC | Andrea B Thomas director | $3,471 50 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.